Monitoring frequency not followed during inspection period – sterility assurance risk explained
Understanding Sterility Assurance Risks from Non-Adhering Monitoring Frequencies In a recent scenario within a sterile pharmaceutical manufacturing facility, a significant deviation was observed during a scheduled FDA inspection. Inspectors identified…